Immunovia AB Stock
Stocks
IMMNOV
SE0006091997
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.1612 SEK | -1.71% |
|
-8.20% | -28.99% |
| 08-13 | Immunovia: Strong demand for blood test for pancreatic cancer, survey shows | FW |
| 08-07 | Immunovia AB, Q2 2026 Earnings Call, Aug 06, 2026 |
| Market Cap | 108M 11.4M 9.85M 9.25M 8.42M 15.82M 1.09B 16.08M 42.4M 546M 42.81M 41.88M 1.81B | P/E 2026 * |
-1.61x | P/E 2027 * | -4.03x |
|---|---|---|---|---|---|
| Enterprise Value | 73.43M 7.72M 6.67M 6.27M 5.7M 10.72M 738M 10.89M 28.71M 370M 28.99M 28.36M 1.23B | EV / Sales 2026 * |
22.9x | EV / Sales 2027 * | 4.53x |
| Free-Float |
89.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Immunovia AB
| 1 day | -1.71% | ||
| 1 week | -8.20% | ||
| Current month | -10.24% | ||
| 1 month | -18.17% | ||
| 3 months | -13.89% | ||
| 6 months | -9.84% | ||
| Current year | -28.99% |
| 1 week | 0.16 |  | 0.17 |
| 1 month | 0.16 | | 0.2 |
| Current year | 0.15 | | 0.25 |
| 1 year | 0.15 | | 0.97 |
| 3 years | 0.15 | | 4.73 |
| 5 years | 0.15 | | 141.5 |
| 10 years | 0.15 | | 298.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | 53 | 2023-04-28 |
Lisa Ford
CTO | Chief Tech/Sci/R&D Officer | 55 | 2024-04-28 |
| Chief Tech/Sci/R&D Officer | 54 | 2024-01-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 2016-12-08 | |
Peter Andersen
CHM | Chairman | 69 | 2023-05-25 |
| Director/Board Member | 51 | 2020-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/15/22 | Buy | Chief Executive Officer | 150,000 | 0.6628% | ||
| 5/24/22 | Buy | Chief Executive Officer | 100,000 | 0.4419% | ||
| 5/21/22 | Buy | Chief Executive Officer | 100,000 | 0.4419% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.71% | -8.20% | -70.26% | -87.27% | 11.53M | |
| +1.02% | +3.49% | +20.90% | -34.10% | 17.03B | |
| -2.98% | +4.48% | -7.86% | +94.13% | 1.82B | |
| -5.24% | -12.38% | -47.19% | -81.65% | 1.03B | |
| -0.44% | -0.07% | -30.41% | +21.34% | 985M | |
| -0.05% | +50.94% | +72.97% | -11.28% | 780M | |
| +0.95% | +5.03% | -36.88% | -50.09% | 690M | |
| +3.92% | +21.65% | -39.26% | -41.27% | 622M | |
| -0.99% | +20.60% | +41.99% | +38.83% | 418M | |
| +5.89% | +11.30% | -41.31% | -39.98% | 417M | |
| Average | +0.04% | +8.17% | -13.73% | -19.13% | 2.38B | |
| Weighted average by Cap. | +0.47% | +4.14% | +11.32% | -22.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2M 336K 291K 273K 248K 467K 32.18M 475K 1.25M 16.11M 1.26M 1.24M 53.55M | 17.3M 1.82M 1.57M 1.48M 1.34M 2.52M 174M 2.57M 6.76M 87.11M 6.83M 6.68M 289M |
| Net income | -87M -9.15M -7.9M -7.43M -6.75M -12.7M -875M -12.9M -34.02M -438M -34.35M -33.6M -1.46B | -76M -7.99M -6.9M -6.49M -5.9M -11.09M -764M -11.27M -29.72M -383M -30.01M -29.35M -1.27B |
| Net Debt | -35M -3.68M -3.18M -2.99M -2.72M -5.11M -352M -5.19M -13.68M -176M -13.82M -13.52M -586M | -30M -3.15M -2.72M -2.56M -2.33M -4.38M -302M -4.45M -11.73M -151M -11.84M -11.59M -502M |
Employees
18
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | SEK 0.1612 | -1.71% | 2,354,934 |
| 26-08-13 | SEK 0.1640 | +1.11% | 1,819,442 |
| 26-08-12 | SEK 0.1622 | +0.37% | 2,644,743 |
| 26-08-11 | SEK 0.1616 | -0.25% | 2,894,590 |
| 26-08-10 | SEK 0.1620 | -2.29% | 2,523,622 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMNOV Stock
Select your edition
All financial news and data tailored to specific country editions
